≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Non-seminoma of testis, including Hilmo

Endpoint Browser PheWeb

C3_TESTIS_NONSEMINOMA_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

only males

244368

2. Check conditions

None

244368

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C62.02&, C62.12&, C62.92&
  • Hospital discharge: ICD-9 — 186B
  • Cause of death: ICD-10 — C62.02&, C62.12&, C62.92&
  • Cause of death: ICD-9 — 186B
  • Cancer registry: Topography ICD-O-3 — C62
  • Cancer registry: Morphology ICD-O-3 — 907[01]|9080|9100
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

243

4. Check minimum number of events

None

243

5. Include endpoints

None

243

6. Filter based on genotype QC (FinnGen only)

226

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 226 - 226
Unadjusted period prevalence (%) 0.10 - 0.10
Median age at first event (years) 30.75 - 30.75

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
234
Matched controls
2340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
223.2
177
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
1320.7
222.4
183
6
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
652.2
168.8
148
6
130
Kela drug reimbursment
Malignant tumour
+∞
144.1
123
*
JN4BD
NOMESCO Finland
Extensive body CT
43.9
142.0
92
34
A03FA01
ATC
metoclopramide; systemic, rectal
27.7
141.1
118
83
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
19.6
83.1
73
53
A04AA01
ATC
ondansetron; systemic, rectal
30.8
73.9
51
21
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
72.8
66
*
JN4AD
NOMESCO Finland
Body CT examination
20.4
70.8
59
38
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
69.3
63
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
58.9
54
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
50.9
47
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
48.7
45
*
L03AA02
ATC
filgrastim; parenteral
292.3
47.9
47
*
H02AB02
ATC
dexamethasone; systemic
73.7
46.6
52
9
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
45.3
42
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
43.1
40
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
174.6
42.3
43
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
39.7
37
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
37.5
35
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.0
32.7
145
576
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.2
32.6
68
144
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
32.0
30
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
32.0
30
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
32.0
30
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
30.9
29
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
29.8
28
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
28.7
27
*
DFF00
NOMESCO Finland
Pure tone audiometry
7.6
28.5
45
71
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
25.5
24
*
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
25.5
24
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
9.0
23.6
31
39
N02AA05
ATC
oxycodone; systemic
6.7
23.3
41
72
B01AB10
ATC
tinzaparin; parenteral
7.6
21.0
32
48
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.1
19
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
19.9
48
113
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
19.4
83
300
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
19.0
18
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
18.4
49
125
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.4
18.3
28
42
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
17.9
17
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
17.9
17
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
194.1
17.8
18
*
B01AB05
ATC
enoxaparin; parenteral
3.9
17.3
64
208
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
16.9
16
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
16.9
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
16.9
16
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
182.5
16.7
17
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
43.5
16.6
20
5
121
Kela drug reimbursment
Severe hypofunction of sexual glands
21.1
15.9
23
12
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
15.8
15
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
15.8
15
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.1
15.5
28
26
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.7
15.1
39
96
WX402
NOMESCO Finland
General anaesthesia
3.4
15.1
67
244
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.8
14.8
25
20
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
14.7
14
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
14.7
14
*
ZXE00
NOMESCO Finland
One hour or less
2.9
13.7
95
445
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
13.7
13
*
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
13.7
13
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
13.3
98
473
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
13.0
33
80
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
12.6
12
*
L03AA13
ATC
pegfilgrastim; parenteral
137.0
12.6
13
*
WZC30
NOMESCO Finland
Teaching
3.7
12.1
44
139
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
11.5
11
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
10.7
79
375
Y78
ICPC
Malign neopl male genital other
+∞
10.5
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.5
10
*
WX320
NOMESCO Finland
Spinalanesthesy
3.2
10.4
48
176
KF8AE, ,
SPAT
5.7
10.3
20
38
WW500
NOMESCO Finland
Blood transfusion
15.5
10.2
16
11
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
14.2
9.8
16
12
C61
ICD-10 Finland
Malignant neoplasm of prostate
104.1
9.5
10
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
9.4
9
*
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
9.4
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
9.3
29
82
N02AX02
ATC
tramadol; systemic, rectal
2.4
9.2
93
506
E29.1
ICD-10 Finland
Testicular hypofunction
5.2
9.0
19
39
Z51.5
ICD-10 Finland
Palliative care
14.8
8.8
14
10
Y05
ICPC
Scrotum/testis sympt/compl other
8.8
8.8
18
22
JN4CD
NOMESCO Finland
Very extensive body CT
28.7
8.6
11
*
N02BE01
ATC
paracetamol; systemic, rectal
3.1
8.5
203
1586
ZX120
NOMESCO Finland
Intravenous
4.1
8.5
24
63
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
8.5
77
397
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
8.4
8
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
8.4
8
*
Z31.8
ICD-10 Finland
Other procreative management
+∞
8.4
8
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
8.4
8
*
M04AA01
ATC
allopurinol; systemic
3.6
8.2
29
89
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
7.9
44
178
N05BA06
ATC
lorazepam; systemic, sublingual
4.4
7.7
20
49
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.8
7.2
23
66
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.4
6.9
12
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
6.8
51
239
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.6
6.7
23
69
GD1AD
NOMESCO Finland
Thorax CT examination
4.1
6.4
18
47
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.5
6.4
11
10
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
+∞
6.3
6
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
6.3
6
*
B01AB04
ATC
dalteparin; parenteral
8.0
6.2
13
17
A02BC02
ATC
pantoprazole; systemic
2.0
6.1
137
971

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
154
5
878.88
178.88
13.2
1.0
3038.20
—
u/l
—
66
0
79
40
29.31
107.49
3.9
1.5
18.33
9.71
iu/l
1.50
55
30
74
40
26.59
97.55
1.1
1.2
—
—
—
0
0
94
96
15.69
88.16
3.6
1.6
8.64
3.94
u/l
4.19
71
84
90
242
5.42
33.16
1.4
1.8
—
—
—
0
0
103
357
4.37
26.75
1.6
1.6
—
—
—
0
0
115
434
4.24
26.52
1.8
1.5
—
—
—
0
0
30
31
10.95
26.45
2.6
6.6
10.00
8.19
%
0.61
30
31
30
31
10.95
26.45
1.3
3.3
43.40
48.65
%
0.51
30
31
102
356
4.31
26.14
1.7
1.8
—
—
—
0
0
107
400
4.09
24.67
6.3
2.1
2.36
2.36
mmol/l
0.10
100
366
100
376
3.90
22.51
2.8
2.4
—
—
—
0
0
125
548
3.75
22.29
3.2
2.6
—
—
estimate
—
0
0
140
663
3.77
22.13
10.1
8.4
1.20
1.20
mmol/l
0.31
117
598
107
438
3.66
20.92
1.4
1.3
—
—
—
0
0
170
976
3.71
18.69
14.7
9.5
3.45
4.14
e9/l
4.25
149
853
94
382
3.44
18.14
3.1
2.9
0.56
0.21
e6/l
0.53
67
266
95
391
3.41
17.92
6.7
4.1
—
—
—
0
0
102
440
3.34
17.80
3.5
2.9
35.98
182.17
e6/l
0.47
75
325
116
548
3.21
17.25
5.4
7.0
—
—
—
0
0
126
627
3.19
17.09
11.2
4.5
36.95
37.68
g/l
0.69
120
594
65
224
3.63
15.99
2.9
2.7
0.60
0.81
e6/l
0.17
33
92
109
519
3.06
15.64
4.3
3.4
48.19
147.69
e6/l
0.55
79
355
25
40
6.88
15.35
2.6
1.7
4.91
2.40
ug/l
1.06
18
34
86
376
3.04
14.11
7.2
3.6
7.40
7.39
ph
1.14
65
265
110
562
2.81
13.38
2.1
2.3
—
—
—
0
0
111
593
2.66
12.07
11.9
9.7
1.18
1.16
inr
0.13
100
493
58
221
3.16
11.87
8.1
10.7
104.10
103.96
mmol/l
0.09
58
221
134
790
2.63
11.83
10.6
9.6
0.00
0.00
e9/l
0.50
102
649
78
364
2.71
10.93
1.6
1.9
1.43
0.81
mg/l
1.62
56
257
40
133
3.42
10.12
1.2
1.1
—
—
—
0
0
142
910
2.43
9.80
6.1
7.8
1.69
1.91
e9/l
2.62
121
814
29
80
4.00
9.61
5.3
2.9
1.23
1.23
mmol/l
0.17
29
72
138
882
2.38
9.46
5.8
7.6
0.60
0.59
e9/l
0.25
112
774
138
885
2.36
9.34
5.8
7.6
0.04
0.04
e9/l
0.86
112
780
60
266
2.69
9.13
2.6
2.4
601.63
564.64
mosm/kgh2o
0.48
54
231
139
906
2.32
8.90
6.0
8.1
0.16
0.19
e9/l
2.31
115
804
63
296
2.54
8.47
3.0
2.4
3.17
2.03
e6/l
0.42
57
268
220
1811
4.59
8.33
26.0
12.1
3.95
3.98
mmol/l
1.15
215
1773
218
1864
3.48
6.07
23.9
10.6
21.96
24.19
mg/l
0.54
189
1466
16
30
5.64
5.96
2.1
3.7
59.13
56.17
%
0.50
16
30
79
466
2.05
5.93
10.6
5.5
—
—
—
0
0
14
23
6.40
5.79
2.1
4.4
3.78
3.68
e9/l
0.07
14
23
226
2044
4.09
5.44
31.7
12.3
87.16
83.02
umol/l
0.84
226
2023
226
2047
4.04
5.28
16.8
8.7
33.73
35.56
u/l
0.86
226
2006
33
150
2.40
4.64
9.4
14.0
—
—
—
0
0
9
12
7.75
4.39
1.1
1.3
—
—
—
0
0
34
168
2.20
3.94
3.0
2.2
—
—
—
0
0
108
787
1.69
3.77
3.1
2.7
0.00
0.00
estimate
-0.00
29
149
24
104
2.46
3.74
8.1
17.8
95.73
93.04
%
2.53
24
104
32
158
2.19
3.72
9.5
16.0
0.45
0.97
mmol/l
0.45
27
134
24
106
2.41
3.59
3.0
2.7
—
—
—
0
0
145
1156
1.67
3.49
3.4
3.1
—
—
—
0
0
32
164
2.10
3.39
9.6
15.5
7.42
7.41
ph
0.13
13
84
106
787
1.63
3.34
3.1
2.7
0.00
0.00
estimate
-0.00
30
153
23
105
2.32
3.21
8.2
17.6
1.23
1.65
%
0.76
23
105
42
243
1.89
3.18
1.8
2.3
—
—
—
0
0
91
663
1.61
3.03
3.2
2.9
6.17
6.12
ph
0.18
56
411
9
21
4.41
3.02
2.6
1.5
0.13
0.19
nmol/l
—
9
13
45
272
1.81
2.97
2.2
1.5
—
—
—
0
0
22
103
2.25
2.91
8.7
17.9
0.55
0.69
%
1.18
22
103
38
225
1.82
2.68
1.9
2.2
—
—
—
0
0
9
25
3.70
2.60
1.1
1.1
—
—
—
0
0
103
797
1.52
2.53
3.2
2.7
0.00
0.00
estimate
-0.00
24
131
13
51
2.64
2.49
1.2
1.5
131.10
205.19
pmol/l
0.80
13
51
8
21
3.91
2.48
1.5
3.4
12.19
12.06
%
—
8
21
9
27
3.42
2.42
1.1
1.1
—
—
—
0
0
8
22
3.73
2.38
2.8
2.8
—
—
—
0
0
31
180
1.83
2.33
5.9
4.5
7.37
7.38
ph
0.29
21
109
215
1986
2.02
2.30
23.7
8.6
—
—
—
0
0
102
800
1.49
2.29
3.8
2.9
1.14
1.34
ug/l
0.69
91
732
0
60
0.00
2.28
0.0
1.1
—
6.95
—
0
43
12
48
2.58
2.22
1.2
1.3
—
—
—
0
0
12
49
2.53
2.14
1.3
1.4
—
—
—
0
0
16
76
2.19
2.08
3.4
3.2
—
—
—
0
0
0
58
0.00
2.07
0.0
6.2
—
—
—
0
0
17
87
2.03
1.85
2.4
4.3
59.05
74.72
e9/l
0.51
11
53
12
54
2.29
1.77
9.8
12.4
0.84
0.91
%
0.29
12
49
7
24
2.97
1.73
1.0
1.5
—
—
—
0
0
11
48
2.36
1.73
1.0
1.2
—
—
—
0
0
24
142
1.77
1.72
3.3
5.0
2.14
0.24
%
1.52
14
34
25
150
1.75
1.71
3.8
5.2
3.50
0.73
%
1.83
15
37
0
49
0.00
1.70
0.0
1.0
—
0.79
—
0
18
64
484
1.44
1.66
3.2
2.1
0.00
0.00
estimate
-0.00
21
116
79
624
1.40
1.61
2.9
2.5
0.00
0.00
estimate
-0.00
26
130
226
2173
2.17
1.54
37.0
15.7
6.40
6.53
e9/l
0.50
218
2133
226
2174
2.16
1.54
37.2
15.7
141.67
147.70
g/l
6.11
226
2151
226
2172
2.18
1.54
36.8
15.6
30.14
30.25
pg
0.54
226
2149
226
2172
2.18
1.54
37.8
16.3
41.86
43.42
%
4.11
226
2146
226
2172
2.18
1.54
36.9
15.7
4.74
4.91
e12/l
3.83
217
2133
226
2171
2.20
1.54
36.8
15.6
89.36
89.34
fl
0.03
226
2148
226
2170
2.21
1.53
37.1
15.7
240.40
242.23
e9/l
0.20
218
2130
17
96
1.83
1.43
2.2
3.2
0.68
0.56
%
0.94
17
96
11
53
2.13
1.41
1.6
1.1
—
—
—
0
0
12
60
2.05
1.40
9.8
11.5
1.48
1.58
%
0.21
12
54
42
303
1.47
1.38
4.0
3.4
543.26
1226.00
ng/l
0.64
34
207
179
1919
0.71
1.32
4.9
4.5
2.85
2.88
mmol/l
0.20
173
1836
8
35
2.33
1.28
1.6
1.3
298.25
299.06
ug/g
—
8
24
27
180
1.57
1.28
1.8
1.8
0.50
0.29
mg/l
0.63
16
97
44
333
1.40
1.13
1.5
1.5
16.60
18.27
nmol/l
0.39
39
294
7
30
2.37
1.13
2.1
3.1
—
—
—
0
0
7
30
2.37
1.13
1.1
1.3
—
—
—
0
0
9
165
0.53
1.13
1.6
1.1
0.98
0.93
g/l
—
9
165
9
165
0.53
1.13
1.4
1.1
1.39
1.42
g/l
—
9
165
18
112
1.66
1.12
4.7
2.3
1.02
0.15
e6/l
0.43
18
104
180
1914
0.74
1.08
4.7
4.2
4.64
4.64
mmol/l
0.02
175
1837
7
33
2.15
1.06
2.7
3.1
—
—
—
0
0
22
147
1.55
1.05
4.0
5.3
0.83
0.06
%
1.80
12
34
5
23
2.20
0.98
2.4
1.6
—
—
—
0
0
5
23
2.20
0.98
2.4
1.6
—
—
—
0
0
5
23
2.20
0.98
2.4
1.6
—
—
—
0
0
5
23
2.20
0.98
2.4
1.6
—
—
—
0
0
11
62
1.81
0.96
1.5
1.2
—
—
—
0
0
6
27
2.25
0.94
5.8
2.1
5.30
4.82
kpa
—
6
27
6
27
2.25
0.94
5.8
2.1
9.03
8.60
kpa
—
6
27
6
27
2.25
0.94
5.8
2.1
3.15
2.39
mmol/l
—
6
7
180
1902
0.77
0.90
4.6
4.2
1.21
1.27
mmol/l
1.85
174
1821
48
383
1.32
0.90
3.3
2.9
0.08
0.01
estimate
0.43
26
139
13
80
1.66
0.86
1.1
1.2
—
—
—
0
0
13
80
1.66
0.86
1.2
1.1
—
—
—
0
0
169
1796
0.79
0.85
3.9
3.6
1.55
1.38
mmol/l
1.91
162
1713
10
57
1.79
0.85
1.2
1.2
—
—
—
0
0
13
81
1.64
0.83
1.2
1.2
—
58.46
—
0
13
28
209
1.39
0.80
1.5
1.8
—
—
—
0
0
29
378
0.73
0.80
1.3
1.3
—
—
—
0
0
6
34
1.78
0.77
1.3
1.3
0.81
0.85
g/l
—
6
25
17
116
1.50
0.76
5.9
4.5
24.18
23.94
mmol/l
0.12
17
116
85
963
0.82
0.76
3.0
2.6
—
—
—
0
0
160
1702
0.81
0.75
5.3
4.9
38.16
38.42
mmol/mol
0.13
154
1645
7
39
1.82
0.73
5.6
2.2
7.42
7.41
ph
—
7
39
5
25
2.02
0.73
2.2
3.8
8.06
8.53
pmol/l
—
5
25
20
144
1.43
0.70
5.2
5.8
0.00
0.00
%
—
10
27
12
77
1.59
0.70
1.2
1.2
—
—
—
0
0
135
1243
1.20
0.69
3.2
3.0
15.03
14.86
pmol/l
0.36
122
1155
5
93
0.53
0.68
1.4
1.5
—
—
—
0
0
68
589
1.22
0.65
3.6
2.8
39.08
53.96
ng/l
0.23
47
334
55
466
1.24
0.65
3.1
2.2
0.61
0.64
ug/l
0.13
33
205
12
80
1.53
0.61
1.1
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
17
124
1.40
0.57
1.2
1.3
—
—
—
0
0
9
135
0.65
0.53
1.1
1.3
196.98
400.31
u/ml
—
9
125
69
611
1.18
0.52
2.3
1.7
93.45
96.72
pmol/l
0.23
44
331
24
189
1.30
0.52
1.2
1.3
—
—
—
0
0
51
440
1.20
0.51
4.7
5.7
—
—
—
0
0
11
78
1.43
0.44
3.6
2.9
57.27
176.78
ng/l
1.29
11
67
31
259
1.23
0.43
1.3
1.3
262.86
291.28
titre
—
7
39
0
16
0.00
0.41
0.0
1.1
—
2.63
—
0
5
0
16
0.00
0.41
0.0
1.0
—
0.28
—
0
7
21
169
1.27
0.40
1.7
1.5
—
—
—
0
0
10
71
1.43
0.40
2.7
5.3
36.96
36.99
°c
—
10
71
11
80
1.39
0.39
1.2
1.3
—
—
—
0
0
161
1674
0.88
0.38
4.0
3.7
5.91
5.92
mmol/l
0.03
151
1573
25
297
0.82
0.36
3.3
3.1
—
—
—
0
0
25
297
0.82
0.36
2.9
3.1
—
—
—
0
0
25
296
0.83
0.35
2.9
3.1
—
—
—
0
0
32
277
1.18
0.33
1.5
1.7
4.05
3.64
mmol/l
0.59
19
191
6
47
1.28
0.32
3.2
1.9
—
—
—
0
0
12
92
1.32
0.32
1.6
1.3
—
—
—
0
0
25
292
0.84
0.31
2.7
2.9
—
—
—
0
0
19
228
0.82
0.31
2.7
3.3
—
—
—
0
0
43
479
0.87
0.30
1.2
1.3
0.73
0.95
u/ml
0.48
11
143
12
94
1.29
0.28
1.1
1.8
6.21
6.04
ph
—
7
51
163
1578
1.11
0.27
3.9
3.7
1.77
1.83
mu/l
0.26
150
1477
24
275
0.86
0.25
2.9
3.2
—
—
—
0
0
176
1803
0.90
0.24
32.2
12.9
336.68
337.66
g/l
0.78
176
1795
82
773
1.09
0.23
2.1
1.9
1.68
1.60
mmol/l
0.28
71
691
5
39
1.29
0.23
1.0
1.1
—
147.85
—
0
11
17
199
0.84
0.22
4.7
4.9
—
—
—
0
0
8
101
0.78
0.21
1.1
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
252.71
—
0
10
0
14
0.00
0.20
0.0
3.4
—
—
—
0
0
48
446
1.10
0.19
4.3
4.3
28.01
69.76
mg/l
1.83
40
319
45
417
1.10
0.18
1.4
1.4
2.63
2.44
g/l
0.32
31
277
10
120
0.83
0.17
3.4
5.1
—
—
—
0
0
8
96
0.83
0.14
2.1
2.9
—
—
—
0
0
11
94
1.18
0.13
1.2
2.0
—
10.02
—
0
6
48
454
1.07
0.13
4.7
5.2
7.75
13.35
mg/mmol
0.46
38
319
16
179
0.89
0.12
1.1
1.1
—
—
—
0
0
10
85
1.18
0.12
11.2
10.4
—
—
—
0
0
40
422
0.94
0.10
1.3
1.5
—
—
—
0
0
11
97
1.14
0.09
1.2
1.7
0.00
0.00
estimate
—
5
34
22
204
1.09
0.09
1.6
1.7
—
—
—
0
0
15
137
1.10
0.07
1.3
1.3
—
—
—
0
0
39
375
1.05
0.06
3.2
3.1
1.02
1.02
kg/l
0.83
26
233
17
158
1.08
0.06
1.1
1.2
—
—
—
0
0
11
100
1.10
0.05
1.2
1.2
—
—
—
0
0
24
238
1.01
0.00
1.4
1.7
404.47
54419033.19
pmol/l
0.50
19
215
11
109
1.01
0.00
1.2
1.1
—
—
—
0
0
61
614
0.99
0.00
4.3
4.4
9.68
9.36
mmol/l
0.16
53
561
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
7.24
—
0
5
0
6
0.00
-0.00
0.0
6.2
—
24.05
—
0
6
0
5
0.00
-0.00
0.0
1.8
—
3.00
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
12.07
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.99
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
35.81
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.3
—
25.38
—
0
8
0
8
0.00
-0.00
0.0
4.8
—
10.50
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
69.33
—
0
6
0
8
0.00
-0.00
0.0
1.6
—
6.31
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_TESTIS_NONSEMINOMA_WIDE – Non-seminoma of testis, including Hilmo

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).